Fennec Pharmaceuticals, Inc. (FENC)
11.74
+0.34
(+2.98%)
USD |
NASDAQ |
Aug 25, 16:00
11.74
0.00 (0.00%)
After-Hours: 19:59
Fennec Pharmaceuticals Total Liabilities (Quarterly) : 33.31M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.31M |
| March 31, 2026 | 34.15M |
| December 31, 2025 | 35.10M |
| September 30, 2025 | 53.75M |
| June 30, 2025 | 52.34M |
| March 31, 2025 | 52.28M |
| December 31, 2024 | 50.82M |
| September 30, 2024 | 64.09M |
| June 30, 2024 | 64.52M |
| March 31, 2024 | 66.18M |
| December 31, 2023 | 38.49M |
| September 30, 2023 | 29.56M |
| June 30, 2023 | 29.16M |
| March 31, 2023 | 29.16M |
| December 31, 2022 | 29.51M |
| September 30, 2022 | 27.62M |
| June 30, 2022 | 7.027M |
| March 31, 2022 | 6.625M |
| December 31, 2021 | 6.642M |
| September 30, 2021 | 7.001M |
| June 30, 2021 | 5.834M |
| March 31, 2021 | 2.892M |
| December 31, 2020 | 2.347M |
| September 30, 2020 | 2.885M |
| June 30, 2020 | 3.19M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.907M |
| December 31, 2019 | 2.271M |
| September 30, 2019 | 0.905M |
| June 30, 2019 | 1.353M |
| March 31, 2019 | 1.451M |
| December 31, 2018 | 1.637M |
| September 30, 2018 | 2.076M |
| June 30, 2018 | 0.847M |
| March 31, 2018 | 1.173M |
| December 31, 2017 | 1.644M |
| September 30, 2017 | 1.03M |
| June 30, 2017 | 0.58M |
| March 31, 2017 | 0.427M |
| December 31, 2016 | 0.402M |
| September 30, 2016 | 0.36M |
| June 30, 2016 | 0.451M |
| March 31, 2016 | 0.345M |
| December 31, 2015 | 0.471M |
| September 30, 2015 | 0.431M |
| June 30, 2015 | 0.759M |
| March 31, 2015 | 1.123M |
| December 31, 2014 | 1.759M |
| September 30, 2014 | 3.901M |
| June 30, 2014 | 5.707M |
| March 31, 2014 | 5.729M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Abeona Therapeutics, Inc. | 51.45M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 75.75M |
| Shareholders Equity (Quarterly) | 42.44M |
| Current Ratio | 5.850 |
| Net Debt Paydown Yield | 0.96% |